Rheumatology Patient Registry and Biorepository

  • STATUS
    Recruiting
  • End date
    Jun 1, 2040
  • participants needed
    5000
  • sponsor
    Yale University
Updated on 23 April 2021
myositis
connective tissue disease
sjogren's syndrome
autoimmune disease
vasculitis
arthritis
rheumatic diseases
rheumatism
prednisolone acetate ophthalmic suspension
sarcoidosis
lupus
polymyalgia rheumatica
reactive arthritis
scleroderma
rheumatoid arthritis
dermatomyositis
spondylitis
giant cell arteritis
arteritis
adult onset still's disease
polymyositis
mixed connective tissue disease
ankylosing spondylitis
polymyalgia
antiphospholipid syndrome

Summary

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Description

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease. Healthy volunteers are also invited to participate in this study.

Details
Condition Dermatomyositis, Rheumatism, Ankylosing spondylitis, Psoriasis, Antiphospholipid Syndrome, Behcet's Syndrome, Adult Onset Still's Disease, Autoimmune disease, CONNECTIVE TISSUE DISEASE, Sicca Syndrome, Reiter's syndrome, PSORIATIC ARTHRITIS, Lyme Disease, Giant Cell Arteritis, Rheumatoid Arthritis, Scleroderma, Systemic sclerosis, Anterior uveitis, Polymyalgia Rheumatica, Myositis, Dermatosis, SYSTEMIC LUPUS ERYTHEMATOSUS, Lyme Disease Vaccine, Musculoskeletal Disease, Lymphoproliferative Disorder, Mixed Connective Tissue Disease, Xerostomia, Sarcoidosis, Arthritis, Polymyositis, Arthritis and Arthritic Pain, Polymyalgia Rheumatica (PMR), Psoriasis and Psoriatic Disorders, Rheumatoid Arthritis (Pediatric), Dermatomyositis (Connective Tissue Disease), Congenital Skin Diseases, Polymyositis (Inflammatory Muscle Disease), Arthritis and Arthritic Pain (Pediatric), Behçet Disease, Behçet Disease, Sjogren's Syndrome, Dry Mouth, Skin Conditions, Connective Tissue Diseases, Musculoskeletal Diseases, Idiopathic Inflammatory Myopathies, Lymphoproliferative disorders, Behçet Disease, Behçet Disease, Behçet Disease, Behçet Disease, rheumatic diseases, rheumatic, temporal arteritis, reactive arthritis, sarcoid, behcet's disease, progressive systemic sclerosis, Behçet Disease, Behçet Disease, Behçet Disease, Behçet Disease, Behçet Disease, Behçet Disease, Behçet Disease, Behçet Disease
Clinical Study IdentifierNCT04402086
SponsorYale University
Last Modified on23 April 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Age 18 years old
No chronic skin conditions
No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis)
Normal BMI

Exclusion Criteria

Unable to provide informed consent
Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman
Allergies to lidocaine or epinephrine (skin biopsies)
A history of impaired wound healing (skin biopsies)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note